Cargando…

Oncogene-induced NAD(+) depletion in tumorigenesis

Detalles Bibliográficos
Autores principales:	Tummala, Krishna S., Djouder, Nabil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468318/ https://www.ncbi.nlm.nih.gov/pubmed/26097866

Ejemplares similares

Boosting NAD(+) for the prevention and treatment of liver cancer
por: Djouder, Nabil
Publicado: (2015)

Adaptive survival mechanism to glucose restrictions
por: Djouder, Nabil
Publicado: (2016)

Nicotinamide riboside or IL-17A signaling blockers to prevent liver disorders
por: Teijeiro, Ana, et al.
Publicado: (2017)

Hepatocellular Carcinomas Originate Predominantly from Hepatocytes and Benign Lesions from Hepatic Progenitor Cells
por: Tummala, Krishna S., et al.
Publicado: (2017)

NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma
por: Kennedy, Barry E., et al.
Publicado: (2022)

Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications
por: Banerjee, Priyanka, et al.
Publicado: (2022)

Oncogenic virus-induced aerobic glycolysis and tumorigenesis
por: Yu, Li, et al.
Publicado: (2018)

Myeloid p38α signaling promotes intestinal IGF‐1 production and inflammation‐associated tumorigenesis
por: Youssif, Catrin, et al.
Publicado: (2018)

Antiplatelet Effect of Carbon Monoxide Is Mediated by NAD(+) and ATP Depletion
por: Kaczara, Patrycja, et al.
Publicado: (2020)

Decreased NAD+ in dopaminergic neurons
por: Sison, Samantha L., et al.
Publicado: (2018)

Lycopene Pretreatment Ameliorates Acute Ethanol Induced NAD(+) Depletion in Human Astroglial Cells
por: Guest, Jade, et al.
Publicado: (2015)

NAD-Glycohydrolase Depletes Intracellular NAD(+) and Inhibits Acidification of Autophagosomes to Enhance Multiplication of Group A Streptococcus in Endothelial Cells
por: Hsieh, Cheng-Lu, et al.
Publicado: (2018)

Bacteria boost host NAD metabolism
por: Shats, Igor, et al.
Publicado: (2020)

NAD(+) to assess health in aging humans
por: Janssens, Georges E., et al.
Publicado: (2022)

NAD+ Precursors: A Physiological Reboot?
por: Niño-Narvión, Julia, et al.
Publicado: (2023)

Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable
por: Xiao, Yang, et al.
Publicado: (2016)

Epithelial NAD(+) depletion drives mitochondrial dysfunction and contributes to intestinal inflammation
por: Novak, Elizabeth A., et al.
Publicado: (2023)

Oncogene-Induced Replication Stress Drives Genome Instability and Tumorigenesis
por: Sarni, Dan, et al.
Publicado: (2017)

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
por: Curtin, Nicola, et al.
Publicado: (2020)

NAD(+) deficit, protein acetylation and muscle aging
por: Ji, Li Li, et al.
Publicado: (2021)

4582 NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD) DEPLETION MUST BE SEVERE TO INDUCE CARDIAC DYSFUNCTION AND EVENTUAL FAILURE
por: Luongo, Timothy, et al.
Publicado: (2020)

Targeting on the NAD(+)‐mitophagy axis to treat cardiovascular disease
por: Fang, Evandro F., et al.
Publicado: (2020)

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
por: DeNicola, Gina M., et al.
Publicado: (2011)

Copper is required for oncogenic BRAF signaling and tumorigenesis
por: Brady, Donita C., et al.
Publicado: (2014)

The forgotten art of cold therapeutic properties in cancer: A comprehensive historical guide
por: Grazioso, Tatiana P., et al.
Publicado: (2023)

Wld(S) Reduces Paraquat-Induced Cytotoxicity via SIRT1 in Non-Neuronal Cells by Attenuating the Depletion of NAD
por: Yu, Qiujing, et al.
Publicado: (2011)

Ozone Exposure Induces Metabolic Disorders and NAD+ Depletion Through PARP1 Activation in Spinal Cord Neurons
por: Ma, Shulin, et al.
Publicado: (2020)

NAD(+) pool depletion as a signal for the Rex regulon involved in Streptococcus agalactiae virulence
por: Franza, Thierry, et al.
Publicado: (2021)

Intracellular NAD(+) Depletion Confers a Priming Signal for NLRP3 Inflammasome Activation
por: Shim, Do-Wan, et al.
Publicado: (2021)

CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019)

Viral Oncogene–Induced DNA Damage Response Is Activated in Kaposi Sarcoma Tumorigenesis
por: Koopal, Sonja, et al.
Publicado: (2007)

When dormancy fuels tumour relapse
por: Santos-de-Frutos, Karla, et al.
Publicado: (2021)

DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD(+) depletion in experimental atrial fibrillation
por: Zhang, Deli, et al.
Publicado: (2019)

The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis
por: Zhou, Yuhang, et al.
Publicado: (2016)

Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
por: Luo, Yongde, et al.
Publicado: (2021)

Oncogenic signaling-mediated regulation of chromatin during tumorigenesis
por: Alam, Jahangir, et al.
Publicado: (2023)

Hepatic mitochondrial NAD(+) transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis
por: Cheng, Lili, et al.
Publicado: (2023)

Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE
por: Bruzzone, Santina, et al.
Publicado: (2009)

NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD(+) depletion
por: Sasaki, Yo, et al.
Publicado: (2016)

Depletion of CDC5L inhibits bladder cancer tumorigenesis
por: Zhang, Ziwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jjofhvhgge3osgi6cca509ngh0